Frontiers in Pharmacology | Renal Pharmacology

Systematic Review

Published on 02 Jun 2025

Tetramethylpyrazine and renal ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical studies

in Renal Pharmacology

Zhongmei Fu
Lianyan Jiang
Xiaojuan Su
Hua Wang
Mingquan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559314

276 views

Original Research

Published on 30 May 2025

ATP/P2X7 receptor/NLRP3 pathway facilitates renal tubular epithelial-myofibroblast transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction

in Renal Pharmacology

Hui Tan
Feiyan Li
Yanchao Cui
Ziwen Li
Shiqiang Yan
Quanfeng Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598151

166 views

Review

Published on 30 May 2025

Preexisting statin therapy is not associated with reduced acute kidney injury following cardiac surgery: a retrospective analysis

in Renal Pharmacology

Jia Wang
Chuzhu Huang
Yan Chen
Yilin Huang
Zhuomin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613681

236 views

Original Research

Accepted on 27 May 2025

Luteolin delays the progression of IgA nephropathy by attenuating inflammation, oxidative stress and reducing extracellular matrix accumulation through activating the Nrf-2/HO-1 pathway

in Renal Pharmacology

Dong-Yu Liang
Shao-Hua Cong
Lin-Hui Li
Qing-Qing Yi
Liping Tang
Li Ou Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530655

209 views

Original Research

Published on 27 May 2025

Xanthohumol ameliorates diabetic kidney disease through suppression of renal fibrosis by regulating SNHG10/miR-378b

in Renal Pharmacology

Jian Hao
Hui Li
Weimin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532517

360 views

Original Research

Accepted on 26 May 2025

Homotherapy for heteropathy of chronic kidney disease and oligoasthenozoospermia through regulating SIRT1/NF-κB pathway by Shenqi pills

in Renal Pharmacology

Shuo Huang
Qihan Luo
Xinyue Li
Yiming Liu
Jiale Wei
Sichen Wang
Ping Qiu
Changyu Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551423

120 views

Original Research

Published on 22 May 2025

Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with adenine-induced chronic renal injury

in Renal Pharmacology

Lulu Huang
Yun Xiao
Xiaoyu Han
Yang Yu
Chao Zheng
Xiangdong Fang
Qing Li
Fanglan Liu
Chunhua Xia
Yongjie Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565713

330 views

Systematic Review

Published on 20 May 2025

The preventive effect of sodium-glucose co-transporter-2 inhibitors on atrial fibrillation and atrial flutter in patients with chronic kidney disease: a meta-analysis

in Renal Pharmacology

Qian Yang
Chen Wang
Wenjing Wang
Yanhong Li
Yi Dang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585491

396 views

Original Research

Accepted on 19 May 2025

Dimethyl malonate alleviates obstructive nephropathy by enhancing renal metabolism and inhibiting kidney oxidative stress and inflammation

in Renal Pharmacology

Wenbin Zhang
Wei Zhang
Changde Fu
Jinjin Lai
Jun Xin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530635

100 views

Original Research

Published on 19 May 2025

Natural products in treating diabetic kidney disease: a visualized bibliometric analysis

in Renal Pharmacology

Tianlong Liu
Xiaolin Li
Yidan Chen
Jinhu Li
Rong Wang
Yi Ding
Minna Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522074

440 views

Original Research

Published on 19 May 2025

Post-marketing safety surveillance of voclosporin: an observational, pharmacovigilance study leveraging faers database study on the safety of voclosporin

in Renal Pharmacology

Zhi Wang
Yanhua Lang
Xuyan Liu
Yuxuan Wang
Leping Shao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506760

459 views

Original Research

Accepted on 16 May 2025

Integrating single-cell RNA-seq, bulk RNA-seq and network pharmacology reveals protective effect of salidroside in peritoneal dialysis-associated peritoneal fibrosis

in Renal Pharmacology

Shuting Li
Yue Ji
Silin Zhu
Mi Liu
Dan Luo
Qimei Luo
Min Mo
Haibo Long
Fenfen Peng
Zhanjun Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558366

169 views

Review

Published on 14 May 2025

Elucidating the function of clusterin in the progression of diabetic kidney disease

in Renal Pharmacology

Lin Mao
Ruili Yin
Longyan Yang
Dong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573654

446 views

Original Research

Published on 13 May 2025

Renal tubular epithelial cell related partial epithelial-mesenchymal transition in AAⅠ induced renal fibrosis via Wnt7b/β-catenin signaling

in Renal Pharmacology

Yi-Fan Wang
Dan Zheng
Ying Zhang
Xiao-Fen Li
Ming Xia
Hai-Ming Tang
Chun-Hua Huang
Mao-Juan Li
Di-Dong Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571960

650 views

Original Research

Published on 13 May 2025

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of OATF against kidney stones

in Renal Pharmacology

Sisi Dai
Qi Fang
Hong-Yan Li
Rui Sun
Hui-Yong Zhang
Wei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1575270

617 views

Original Research

Published on 13 May 2025

Stromal vascular fraction inhibits renal fibrosis by regulating metabolism and inflammation in obstructive nephropathy

in Renal Pharmacology

Guang Yue
Yunjie Yang
Hongshuai Jia
Yangyang Wu
Lifei Ma
Xiaoyu Yi
Yuandong Tao
Huixia Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559446

501 views